{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T17:03:37Z","timestamp":1756573417846},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T00:00:00Z","timestamp":1723334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology Reports"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.gore.2024.101484","type":"journal-article","created":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T22:43:06Z","timestamp":1723502586000},"page":"101484","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Discrepancy in PD-L1 expression between primary and metastatic tumors in two patients with recurrent cervical cancer"],"prefix":"10.1016","volume":"55","author":[{"given":"Brittany","family":"File","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjali","family":"Hari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"doi-asserted-by":"crossref","unstructured":"Callea M, Albiges L, Gupta M, Cheng SC, Genega EM, Fay AP, et al. Differential expression of PD-L1 between primary and metastatic sites in clear-cell renal cell carcinoma. Cancer Immunol Res 2015;3. doi: 10.1158\/2326-6066.CIR-15-0043.","key":"10.1016\/j.gore.2024.101484_b0005","DOI":"10.1158\/2326-6066.CIR-15-0043"},{"key":"10.1016\/j.gore.2024.101484_b0010","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.1825","article-title":"Nanotechnology in the management of cervical cancer","volume":"25","author":"Chen","year":"2015","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.gore.2024.101484_b0015","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2112435","article-title":"Pembrolizumab for persistent, recurrent, or metastatic cervical cancer","volume":"385","author":"Colombo","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.gore.2024.101484_b0020","doi-asserted-by":"crossref","DOI":"10.1038\/modpathol.2016.64","article-title":"Prognostic effect of different PD-L1 expression patterns in squamous cell carcinoma and adenocarcinoma of the cervix","volume":"29","author":"Heeren","year":"2016","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.gore.2024.101484_b0025","doi-asserted-by":"crossref","DOI":"10.1038\/s41379-021-00780-3","article-title":"Clinicopathologic and genomic characterization of PD-L1-positive uterine cervical carcinoma","volume":"34","author":"Huang","year":"2021","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.gore.2024.101484_b0030","doi-asserted-by":"crossref","DOI":"10.1186\/s13000-020-00977-1","article-title":"Variation of PD-L1 expression in locally advanced cervical cancer following neoadjuvant chemotherapy","volume":"15","author":"Liang","year":"2020","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.gore.2024.101484_b0035","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2016.6073","article-title":"Increased expression of PD-L1 by the human papillomavirus 16 E7 oncoprotein inhibits anticancer immunity","author":"Liu","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.gore.2024.101484_b0040","article-title":"Comparison of PD-L1 expression and MMR status between primary and matched metastatic lesions in patients with cervical cancer","volume":"149","author":"Liu","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.gore.2024.101484_b0045","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2020.38.15_suppl.TPS6096","article-title":"ENGOT-cx11\/KEYNOTE-A18: a phase III, randomized, double-blind study of pembrolizumab with chemoradiotherapy in patients with high-risk locally advanced cervical cancer","volume":"38","author":"Lorusso","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.gore.2024.101484_b0050","doi-asserted-by":"crossref","DOI":"10.1111\/pcmr.12340","article-title":"PD-L1 expression in melanoma shows marked heterogeneity within and between patients: Implications for anti-PD-1\/PD-L1 clinical trials","volume":"28","author":"Madore","year":"2015","journal-title":"Pigm. Cell Melanoma Res."},{"key":"10.1016\/j.gore.2024.101484_b0055","doi-asserted-by":"crossref","DOI":"10.7150\/jca.22532","article-title":"PD-L1 expression correlates with tumor infiltrating lymphocytes and response to neoadjuvant chemotherapy in cervical cancer","volume":"9","author":"Meng","year":"2018","journal-title":"J. Cancer"},{"key":"10.1016\/j.gore.2024.101484_b0060","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.25770","article-title":"PD-L1 expression comparison between primary and relapsed non-small cell lung carcinoma using whole sections and clone SP263","volume":"9","author":"Munari","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.gore.2024.101484_b0065","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-83276-z","article-title":"Differential expression of PD-L1 between primary and metastatic epithelial ovarian cancer and its clinico-pathological correlation","volume":"11","author":"Parvathareddy","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.gore.2024.101484_b0070","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.35.15_suppl.5514","article-title":"Pembrolizumab for previously treated advanced cervical squamous cell cancer: preliminary results from the phase 2 KEYNOTE-158 study","volume":"35","author":"Schellens","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.gore.2024.101484_b0075","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-50898-3","article-title":"Expression of PD-1\/PD-L1 in primary breast tumours and metastatic axillary lymph nodes and its correlation with clinicopathological parameters","volume":"9","author":"Yuan","year":"2019","journal-title":"Sci. Rep."}],"container-title":["Gynecologic Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578924001632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578924001632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T12:08:07Z","timestamp":1727266087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352578924001632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":15,"alternative-id":["S2352578924001632"],"URL":"https:\/\/doi.org\/10.1016\/j.gore.2024.101484","relation":{},"ISSN":["2352-5789"],"issn-type":[{"type":"print","value":"2352-5789"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discrepancy in PD-L1 expression between primary and metastatic tumors in two patients with recurrent cervical cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gore.2024.101484","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101484"}}